LEADER 04608nam 2200565 450 001 9910814035003321 005 20210930145448.0 010 $a1-119-04153-8 010 $a1-119-04155-4 010 $a1-119-04154-6 035 $a(CKB)3710000000498277 035 $a(EBL)4054887 035 $a(MiAaPQ)EBC4054887 035 $a(Au-PeEL)EBL4054887 035 $a(CaPaEBR)ebr11117524 035 $a(CaONFJC)MIL847001 035 $a(OCoLC)929532619 035 $a(PPN)223892645 035 $a(EXLCZ)993710000000498277 100 $a20160111h20162016 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 00$aHandbook of polymers for pharmaceutical technologies /$fedited by Vijay Kumar Thakur and Manju Kumari Thakur 210 1$aHoboken, New Jersey ;$aSalem, Massachusetts :$cJohn Wiley & Sons :$cScrivener Publishing,$d2016. 210 4$d©2016 215 $a1 online resource (434 p.) 300 $aIncludes index. 311 $a1-119-04146-5 327 $a""Title Page""; ""Copyright Page""; ""Dedication""; ""Contents""; ""Preface""; ""1 Smart Hydrogels: Therapeutic Advancements in Hydrogel Technology for Smart Drug Delivery Applications""; ""1.1 Introduction""; ""1.2 Types and Properties of Smart Polymer Hydrogels""; ""1.2.1 Temperature-Responsive Hydrogels""; ""1.2.2 pH-Sensitive Hydrogels""; ""1.2.3 Glucose-Responsive Hydrogels""; ""1.2.4 Electro-Signal Sensitive Hydrogels""; ""1.2.5 Light-Sensitive Hydrogels""; ""1.2.6 Multi-Responsive Smart Hydrogels""; ""1.3 Applications of Smart Polymer Hydrogels""; ""1.4 Conclusion""; ""References"" 327 $a""2 Molecularly Imprinted Polymers for Pharmaceutical Applications""""2.1 Introduction""; ""2.2 Fluoroquinolone Antibiotics""; ""2.3 Sulfonamides""; ""2.4 Miscellaneous""; ""2.5 Conclusions and Future Prospects""; ""2.6 Acronyms and Abbreviations""; ""References""; ""3 Polymeric Stabilizers for Drug Nanocrystals""; ""3.1 Introduction""; ""3.2 Methods for Nanocrystallization""; ""3.2.1 Bottom-Up Technologies""; ""3.2.2 Top-Down Technologies""; ""3.2.3 Combination Technologies""; ""3.3 Stabilization Mechanisms of the Nanocrystals""; ""3.4 Polymers for Nanocrystal Stabilization"" 327 $a""3.4.1 Polymers of Natural Origin""""3.4.2 Synthetic Polymers""; ""3.5 Effect of Stabilizing Polymers on Drug Biocompatibility, Bioactivity, Membrane Permeability and Drug Absorption""; ""3.6 Conclusions and Future Perspective""; ""References""; ""4 Polymeric Matrices for the Controlled Release of Phosphonate Active Agents for Medicinal Applications""; ""4.1 Introduction""; ""4.2 Polymers in Drug Delivery""; ""4.2.1 Polyesters""; ""4.2.1.1 Poly(lactic acid), Poly(glycolic acid), and Their Copolymers""; ""4.2.1.2 Poly(ethylene glycol) Block Copolymers""; ""4.2.1.3 Poly(ortho esters)"" 327 $a""4.2.1.4 Poly(anhydrides)""""4.2.1.5 Poly(anhydride-imides)""; ""4.2.1.6 Poly(anhydrite esters)""; ""4.2.2 Poly(amides)""; ""4.2.3 Poly(iminocarbonates)""; ""4.3 Release of Phosphonate-Based Drugs""; ""4.4 Conclusions/Perspectives""; ""References""; ""5 Hydrogels for Pharmaceutical Applications""; ""5.1 Introduction""; ""5.2 What are Hydrogels?""; ""5.3 Classification of Hydrogels""; ""5.4 Preparation of Hydrogels""; ""5.5 Characterization of Hydrogels""; ""5.6 Application of Hydrogels""; ""5.6.1 Wound Dressing""; ""5.6.2 Implantable Drug Delivery Systems"" 327 $a""5.6.3 Tissue Engineering Substitute""""5.6.4 Injectable Hydrogels""; ""5.7 Conclusion""; ""Acknowledgement""; ""References""; ""6 Responsive Plasmid DNA Hydrogels: A New Approach for Biomedical Applications""; ""6.1 Introduction""; ""6.2 DNA-Based Hydrogels""; ""6.3 Controlled and Sustained Release""; ""6.3.1 Photodisruption of Plasmid DNA Networks""; ""6.3.2 Release of Plasmid DNA""; ""6.3.3 Release of Chemotherapeutic Drugs""; ""6.3.4 In Vitro Studies""; ""6.4 Combination of Chemo and Gene Therapies""; ""6.5 Conclusions and Future Perspectives""; ""References"" 327 $a""7 Bioactive and Compatible Polysaccharides Hydrogels Structure and Properties for Pharmaceutical Applications"" 606 $aPolymers in medicine 606 $aPharmaceutical technology 615 0$aPolymers in medicine. 615 0$aPharmaceutical technology. 676 $a615.1/9 702 $aThakur$b Vijay Kumar$f1981- 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910814035003321 996 $aHandbook of polymers for pharmaceutical technologies$93995159 997 $aUNINA LEADER 06118nam 22006735 450 001 9910300350003321 005 20250716094804.0 010 $a1-4939-0900-2 024 7 $a10.1007/978-1-4939-0900-1 035 $a(CKB)3710000000187132 035 $a(EBL)1782043 035 $a(OCoLC)889268061 035 $a(SSID)ssj0001297121 035 $a(PQKBManifestationID)11743124 035 $a(PQKBTitleCode)TC0001297121 035 $a(PQKBWorkID)11352944 035 $a(PQKB)10213634 035 $a(MiAaPQ)EBC1782043 035 $a(DE-He213)978-1-4939-0900-1 035 $a(PPN)179922203 035 $a(EXLCZ)993710000000187132 100 $a20140714d2014 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aInnovations in HIV Prevention Research and Practice through Community Engagement /$fedited by Scott D. Rhodes 205 $a1st ed. 2014. 210 1$aNew York, NY :$cSpringer New York :$cImprint: Springer,$d2014. 215 $a1 online resource (274 p.) 300 $aDescription based upon print version of record. 311 08$a1-4939-0899-5 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aAuthentic community engagement and community-based participatory research for public health and medicine -- HIV prevention in a rural community: Multigenerational community engagement.-Preventing HIV among black men in college using a CBPR approach -- Gay community involvement in prevention: Where we have been, where we are, and where we should be going -- HIV prevention interventions with adolescents: Innovations and challenges in partnerships across the integrated transitions model -- Community engagement and HIV prevention with American Indian communities: Working with the whole person -- Applying a CBPR approach to prevent HIV within ethnic, sexual, and gender minority communities: A partnership?s successes with sustainability -- Community involvement in policy interventions -- Communities and technology: Enhancements in HIV prevention research and practice among youth and young adults -- Employment as a social determinant of health: An urban partnership?s experience with intervention development and implementation using CBPR.-Dissemination, implementation, and adaptation of evidence-based behavioral HIV prevention interventions through community engagement: The CDC experience.                   . 330 $aHIV continues to be a profound challenge facing communities nationally and internationally.  Until a vaccine or a cure is found, prevention remains a most crucial line of defense. However, the successes made to reduce exposure and transmission have not benefited all communities equally. HIV continues to affect vulnerable communities, and HIV-related health disparities are growing.  The work documented in Innovations in HIV Prevention Research and Practice through Community Engagement spotlights the effectiveness of community involvement to reduce HIV infections in the United States. This timely resource introduces the concepts of community engagement, partnership, and community-based participatory research (CBPR). Contributors provide detailed examples of these concepts in which diverse research partners blend their unique insights and skills to arrive at an authentic understanding of phenomena and inform the translation of best practices and processes to enhance equity in HIV prevention and treatment. Equitable interactive collaboration is central to these efforts, in which community members and representatives from organizations, the scientific and medical sectors, and other relevant agencies nurture long-term health improvement through sustained teamwork. Challenges and barriers to effective engagement are identified, as are characteristics of successful partnerships. Included in the book: Details of a multigenerational HIV prevention intervention in a rural southeastern community. The challenges and successes of developing, implementing, and evaluating an intervention for higher-risk predominately heterosexual black men in college. The history of gay community involvement in HIV prevention and its contributions to the theory and current practice of engagement. Next steps in the integration of HIV-related policy change and research. Community engagement within American Indiancommunities. Keys to sustaining a CBPR partnership to prevent HIV within ethnic, sexual, and gender minority communities.  Innovations in HIV Prevention Research and Practice through Community Engagement offers researchers and practitioners in public health, community health, and medicine guidance on community engagement that is both inspiring and realistic.  ?Community engagement and knowledge continue to be essential to prevent HIV infections.  This book is a compilation of the state-of-the-science of engagement and delves deeper into the meaning and utilization of community-based participatory research, with implications that reach beyond the HIV epidemic to public health and medicine in general.? -          Laura C. Leviton, PhD, Senior Advisor for Evaluation, Robert Wood Johnson Foundation, Princeton, NJ  . 606 $aMedicine, Preventive 606 $aHealth promotion 606 $aSociology 606 $aClinical health psychology 606 $aHealth Promotion and Disease Prevention 606 $aSociology 606 $aHealth Psychology 615 0$aMedicine, Preventive. 615 0$aHealth promotion. 615 0$aSociology. 615 0$aClinical health psychology. 615 14$aHealth Promotion and Disease Prevention. 615 24$aSociology. 615 24$aHealth Psychology. 676 $a301 676 $a362.1969792 676 $a610 676 $a613 702 $aRhodes$b Scott D$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910300350003321 996 $aInnovations in HIV Prevention Research and Practice through Community Engagement$91521792 997 $aUNINA